References
Simpson JL. Molecular approaches to common causes of female infertility. Best Pract Res Clin Obstet Gynaecol 2002;16:685-702.
Shah K, Sivapalan G, Gibbons N, Tempest H, Griffin D. The genetic basis of infertility. Reproduction 2003;126:13-25.
Davison RM, Fox M, Conway GS. Mapping of the POF1 locus and identification of puatattive genes for primary ovarian failure. Mol Hum Reprod 2000;6:314-318.
Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study. J Clin Endocrinol Metab 1998;83:3078-3082.
Franks S. Medical Progress Article: Polycystic ovary syndrome. N Engl J Med 1995;333:853-861.
Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic Ovary Syndrome. Oxford: Blackwell Scientific Publications, 1992:377-384.
Simpson JL. Elucidating the genetics of polycystic ovary syndrome. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic Ovary Syndrome. Oxford: Blackwell Scientific Publications, 1992:59-77.
Legro RS. The genetics of polycystic ovary syndrome. Am J Med 1995;98(Suppl 1A):9S-16S.
Franks S, Gharani N, Waterworth D, Batty S, White D, Williamson R, McCarthy M. The genetic basis of polycystic ovary syndrome. Hum Reprod 1997;12:2641-2648.
Franks S, Gharani N, McCarthy M. Candidate genes in polycystic ovary syndrome. Hum Reprod Update 2001;7:405-410.
Carey AH, Chan KL, Short F, White DM, Williamson R, Franks S. Evidence for a single gene effect in polycystic ovaries and male pattern baldness. Clin Endocrinol 1993;38:653-658.
Legro RS, Driscoll D, Strauss JF III, Fox J, Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci 1998;95:14956-14960.
Urbanek M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA, Norman RJ, Strauss JF, Spielman RS, Dunaif A. Thirty-seven candidate genes for polycystic ovary syndrome: Strongest evidence for linkage is with follistatin. Proc Natl Acad Sci USA 1999;96:8573-8578.
Legro RS, Kuselman AR, Demers L, Wang SC, Bentley-Lewis R, Dunaif A. Elevated dehydroepiandrosterone sulfate levels as reproductive phenotype in brothers of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:2134-2138.
Steingold K, De Ziegler D, Cedars M, Meldrum DR, Lu JK, Judd HL, Chang RJ. Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease. J Clin Endocrinol Metab 1987;65:773-778.
Gilling-Smith C, Willis DS, Beard RW, Franks S. Hypersecretion of androstenedione by isolated theca cells from polycystic ovaries. J Clin Endocrinol Metab 1994;79:1158-1165.
Nelson VL, Legro RS, Strauss JF III, McAllister JM. Augmented androgen production is a stable phenotype in propagated theca cells from polycystic ovaries. Mol Endo 1999;13:946-957.
Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Brit Med J 1986;293:355-359.
Franks S. Polycystic ovary syndrome: A changing perspective. Clin Endocrinol 1989;31:87-120.
Dunaif A. Insulin resistance and the polycystic ovary syndrome: Mechanism of action and implications for pathogenesis. Endocrine Rev 1996;18:774-800.
Holte J, Bergh T, Berne C, Wide L, Lithell H. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 1995;80:2586-2593.
Hughesden PE. Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called hyperthecosis. Obstet Gynecol Survey 1982;37:59-77.
Webber L, Stubbs S, Stark J, Trew G, Margara R, Hardy K, Franks S. Formation and development of follicles in the polycystic ovary. Lancet 2003 (in press).
Spielman RS, Ewens WJ. The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 1996;59:983-989.
Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and non-parametric linkage analysis: A unified multipoint approach. Am J Hum Genet 1996;58:1347-1363.
Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000;26:76-80.
Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, Hitman GA, Walker M, J Levy JC, Sampson MJ, Halford S, McCarthy MI, Hattersley AT, Frayling TM. Large scale association studies of variants in genes encoding the pancreatic beta-cell K-ATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with increased risk of Type 2 Diabetes. Diabetes 2003;52:568-572.
Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genetics in Medicine 2002;4:45-61.
Haddad L, Evans JC, Gharani N, Robertson C, Rush K, Wiltshire S, Frayling TM, Wilkin TJ, Demaine A, Millward A, Hattersley AT, Conway G, Cox NJ, Bell GI, Franks S, McCarthy MI. Variation within the type 2 diabetes susceptibility gene calpain-10 (CAPN10) and polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:2606-2610.
Cardon LR, Bell JI. Association study designs for complex disease. Nat Rev Genet 2001;2;91-99.
Editorial. Freely associating. Nat Genet 1999;22:1-2.
Tapanainen JS, Koivunen R, Fauser BC, Taylor AE, Clayton RN, Rajkowa M, White D, Franks S, Anttila L, Pettersson KS, Huhtaniemi IT. A new contributing factor to polycystic ovary syndrome: The genetic variant of luteinizing hormone. J Clin Endocrinol Metab 1999;84:1711-1715.
Gharani N, Segaloff D, Guo S-Y, Liu X, Willis D, McCarthy M, Franks S. Molecular scanning of the LH receptor gene in hyperandrogenic women with polycystic ovary syndrome. Proceedings of the Endocrine Society, 80th Annual Meeting, New Orleans 1998, Abstract P1-365.
Gharani N, Waterworth DM, Batty S, White D, Gilling-Smith C, Conway GS, McCarthy M, Franks S, Williamson R. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet 1997;6:397-402.
Pugeat M, Cousin P, Nicolas MH, Mirakian P, Sayegh M, Barret C, Ducros CI, Dechaud H, Forest MG, Lejeune H. Pentanucleotide repeat polymorphism in the promoter region of the human CYP11a gene and polycystic ovaries in hirsute women. Proceedings of the Endocrine Society, 81st Annual Meeting 1999, San Diego California, abstract OR29-1.
Diamanti-Kandarakis E, Bartzis MI, Bergiele AT, Tsianateli TC, Kouli. Microsatellite polymorphism (tttta)(n) at ñ528 base pairs of gene CYP11a alpha influences hyperandrogenemia in patients with polycystic ovary syndrome. Fertil Steril 2000;73:735-741.
Rosenfield RL, Barnes RB, Cara JF, Lucky AW. Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome. Fertil Steril 1990;53:785-791.
Carey AH, Waterworth D, Patel K, White D, Little J, Novelli P, Franks S, Williamson R. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 1994;3:1873-1876.
Gharani N, Waterworth DM, Williamson R, Franks S. 5′ polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries (letter). J Clin Endocrinol Metab 1996;81:4174.
Waterworth DM, Bennett ST, Gharani N, McCarthy MI, Hague S, Batty S, Conway GS, White D, Todd JA, Franks S, Williamson R. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet 1997;349:986-990.
Ong KK, Phillips DI, Fall C, Poulton J, Bennett ST, Golding J, Todd JA, Dunger DB. The insulin gene VNTR, type 2 diabetes and birth weight. Nat Genet 1999;21:262-263.
Bennett ST, Todd JA, Waterworth DM, Franks S, McCarthy MI. Association of insulin gene VNTR polymorphism with polycystic ovary syndrome (letter). Lancet 1997;349:1771-1772.
Huxtable SJ, Saker PJ, Haddad L, Walker M, Frayling TM, Levy JC, Hitman GA, O'Rahilly S, Hattersley AT, McCarthy MI. Analysis of parent-offspring trios provides evidence for linkage and association between the insulin gene and type 2 diabetes mediated exclusively through paternally transmitted Class III variable number tandem repeat alleles. Diabetes 2000;49:126-130.
Conway GS, Avey C, Rumsby G. The tyrosine kinase domain of the insulin receptor gene is normal in women with hyperinsulinaemia and polycystic ovary syndrome. Hum Reprod 1994;9:1681-1683.
Talbot JA, Bicknell EJ, Rajkhowa M, Krook A, O'Rahilly S, Clayton RN. Molecular scanning of the insulin receptor gene in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1996;81:1979-1983.
Tucci S, Futterweit W, Concepcion ES, Greenberg DA, Villenueva R, Davies TF, Tomer Y. A Evidence of association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor gene. J Clin Endocrinol Metab 2001;86:446-449.
Villuendas G, Escobar-Morreale HF, Tosi F, Sancho J, Moghetti P, San Millan JL. Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome (comment). Fertil Steril 2003;79:219-220.
El Mkadem SA, Lautier C, Marcari F, Molinari N, Lefebvre P, Renard E, Gris JC, Cros G, Daures JP, Bringer J, White MF, Grigorescu F. Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome. Diabetes 2001;50:2164-2168.
Ehrmann DA, Tang X, Yoshiuchi I, Cox NJ, Bell GI. Relationship of insulin receptor substrates-1 and ñ2 genotypes to phenotypic features of polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:4297-4300.
Ehrmann DA, Schwarz PE, Hara M, Tang X, Horikawa Y, Imperial J, Bell GI, Cox NJ. Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:1169-1673.
Hara M, Alcoser SY, Qaadir A, Beiswenger K, Cox NJ, Ehrmann DA. Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro12Ala polymorphism in the PPARg gene. J Clin Endocrinol Metab 2002;87:772-775.
Urbanek M, Du Y, Silander K, Collins FS, Steppan CM, Strauss JM, Dunaif A, Spielman RS, Legro RS. Variation in resistin gene promoter not associated with polycystic ovary syndrome. Diabetes 2003;52:214-217.
Urbanek M, Proceedings of “Polycystic Ovary Syndrome: Basic Biology and Clinical Intervention,” National Institute of Environmental of Health Sciences (NIH), Sept. 2000.
Franks S, Mason D, Willis D. Follicular dynamics in the polycystic ovary syndrome. Mol Cell Endocrinol 2000;163:49-52.
Abbott DH, Dumesic DA, Franks S. Developmental origin of polycystic ovary syndrome ñ a hypothesis. J Endocrinol 2002;174:1-5.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Franks, S., McCarthy, M. Genetics of Ovarian Disorders: Polycystic Ovary Syndrome. Rev Endocr Metab Disord 5, 69–76 (2004). https://doi.org/10.1023/B:REMD.0000016125.05878.96
Issue Date:
DOI: https://doi.org/10.1023/B:REMD.0000016125.05878.96